Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

2I8B

Crystal structure of the C-terminal domain of Ebola virus VP30

Summary for 2I8B
Entry DOI10.2210/pdb2i8b/pdb
DescriptorMinor nucleoprotein VP30 (2 entities in total)
Functional Keywordsvp30 ebola virus protein, transcription, rna binding, viral protein
Biological sourceZaire ebolavirus
Cellular locationVirion: Q05323
Total number of polymer chains2
Total formula weight35071.14
Authors
Muziol, T.M.,Hartlieb, B.,Becker, S.,Weissenhorn, W. (deposition date: 2006-09-01, release date: 2007-01-23, Last modification date: 2024-10-09)
Primary citationHartlieb, B.,Muziol, T.,Weissenhorn, W.,Becker, S.
Crystal structure of the C-terminal domain of Ebola virus VP30 reveals a role in transcription and nucleocapsid association.
Proc.Natl.Acad.Sci.Usa, 104:624-629, 2007
Cited by
PubMed Abstract: Transcription of the highly pathogenic Ebola virus depends on VP30, a nucleocapsid-associated Ebola virus-specific transcription factor. The transcription activator VP30 was shown to play an essential role in Ebola virus replication, most likely by stabilizing nascent mRNA. Here we present the crystal structure of the C-terminal domain (CTD) of VP30 (VP30(CTD)) at 2.0-A resolution. VP30(CTD) folds independently into a dimeric helical assembly. The VP30(CTD) dimers assemble into hexamers that are present in virions, by an oligomerization domain located in the N terminus of VP30. Mutagenesis of conserved charged amino acids on VP30(CTD) revealed that two regions, namely a basic cluster around Lys-180 and Glu-197, are required for nucleocapsid interaction. However, only mutagenesis of the basic cluster was shown to impair transcription activation, suggesting that both processes are regulated independently. The structure and the mutagenesis results reveal a potential pocket for small-molecule inhibitors that might prevent VP30 activity and thus virus propagation as it has been shown previously by peptides, which interfere with VP30 homooligomerization.
PubMed: 17202263
DOI: 10.1073/pnas.0606730104
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2 Å)
Structure validation

227933

数据于2024-11-27公开中

PDB statisticsPDBj update infoContact PDBjnumon